Risk factors of peritoneal dialysis-related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

Yasuhiko Ito, Charlotte Tu, Makoto Yamaguchi, S. Koide, M. Ryuzaki, B. Bieber, R. Pisoni, Jeffrey Perl, Jun Minakuchi, Hideki Kawanishi, Hideki Kawanishi, Jun Minakuchi, Tadashi Tomo, Ken Tsuchiya, Kousaku Nitta, M. Ryuzaki, Mizuya Fukazawa, Yasuhiro Ito, Hidetomo Nakamoto, Akihiro C Yamashita
{"title":"Risk factors of peritoneal dialysis-related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)","authors":"Yasuhiko Ito, Charlotte Tu, Makoto Yamaguchi, S. Koide, M. Ryuzaki, B. Bieber, R. Pisoni, Jeffrey Perl, Jun Minakuchi, Hideki Kawanishi, Hideki Kawanishi, Jun Minakuchi, Tadashi Tomo, Ken Tsuchiya, Kousaku Nitta, M. Ryuzaki, Mizuya Fukazawa, Yasuhiro Ito, Hidetomo Nakamoto, Akihiro C Yamashita","doi":"10.1093/ckj/sfae202","DOIUrl":null,"url":null,"abstract":"\n \n \n Peritoneal dialysis (PD)-related peritonitis is a major complication of PD. Wide variations in peritonitis prevention, treatment strategies, and consequences are seen between countries. These between-country differences may result from modifiable risk factors and clinical practices.\n \n \n \n A total of 1225 Japanese PD patients were included and prospectively followed in the Peritoneal Dialysis Outcomes and Practice Patterns Study phase 1 (2014–2018) and phase 2 (2018–2022). Associations between PD-related peritonitis and various risk factors were assessed by Cox proportional hazards survival models.\n \n \n \n During follow-up (median 1.52 years), 539 peritonitis episodes were experienced by 364 patients. The country crude peritonitis rate was 0.27 episodes/patient-year. In the fully adjusted model, noticeable patient-level factors associated with experiencing any peritonitis included age (hazard ratio [HR], 1.07 per 5-year increase; 95% confidence interval [CI], 1.01–1.14), serum albumin level (HR, 0.63 per 1 g/dL higher; 95% CI, 0.48–0.82) and continuous ambulatory peritoneal dialysis (HR, 1.31 vs automated PD; 95% CI, 1.05–1.63). The adoption of antibiotic prophylaxis practice at the time of PD catheter insertion (HR, 0.63; 95% CI, 0.51–0.78), or when having complicated dental procedures (HR, 0.74; 95% CI, 0.57–0.95), or lower endoscopy (HR, 0.69; 95% CI, 0.54–0.89) were associated with lower hazards of any peritonitis while a routine facility practice of having more frequent regular medical visits was associated with a higher hazard.\n \n \n \n Identification of risk factors in Japan may be useful for developing future versions of guidelines and improving clinical practices in Japan. Investigation of country-level risk factors for PD-related peritonitis is useful for developing and implementing local peritonitis prevention and treatment strategies.\n","PeriodicalId":505254,"journal":{"name":"Clinical Kidney Journal","volume":"14 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Kidney Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ckj/sfae202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Peritoneal dialysis (PD)-related peritonitis is a major complication of PD. Wide variations in peritonitis prevention, treatment strategies, and consequences are seen between countries. These between-country differences may result from modifiable risk factors and clinical practices. A total of 1225 Japanese PD patients were included and prospectively followed in the Peritoneal Dialysis Outcomes and Practice Patterns Study phase 1 (2014–2018) and phase 2 (2018–2022). Associations between PD-related peritonitis and various risk factors were assessed by Cox proportional hazards survival models. During follow-up (median 1.52 years), 539 peritonitis episodes were experienced by 364 patients. The country crude peritonitis rate was 0.27 episodes/patient-year. In the fully adjusted model, noticeable patient-level factors associated with experiencing any peritonitis included age (hazard ratio [HR], 1.07 per 5-year increase; 95% confidence interval [CI], 1.01–1.14), serum albumin level (HR, 0.63 per 1 g/dL higher; 95% CI, 0.48–0.82) and continuous ambulatory peritoneal dialysis (HR, 1.31 vs automated PD; 95% CI, 1.05–1.63). The adoption of antibiotic prophylaxis practice at the time of PD catheter insertion (HR, 0.63; 95% CI, 0.51–0.78), or when having complicated dental procedures (HR, 0.74; 95% CI, 0.57–0.95), or lower endoscopy (HR, 0.69; 95% CI, 0.54–0.89) were associated with lower hazards of any peritonitis while a routine facility practice of having more frequent regular medical visits was associated with a higher hazard. Identification of risk factors in Japan may be useful for developing future versions of guidelines and improving clinical practices in Japan. Investigation of country-level risk factors for PD-related peritonitis is useful for developing and implementing local peritonitis prevention and treatment strategies.
日本腹膜透析结果和实践模式研究(PDOPPS)中腹膜透析相关腹膜炎的风险因素
腹膜透析(PD)相关腹膜炎是腹膜透析的主要并发症。各国在腹膜炎的预防、治疗策略和后果方面存在很大差异。这些国家间的差异可能源于可改变的风险因素和临床实践。 腹膜透析结果和实践模式研究第一阶段(2014-2018 年)和第二阶段(2018-2022 年)共纳入了 1225 名日本腹膜透析患者,并对其进行了前瞻性随访。通过 Cox 比例危险生存模型评估了腹膜透析相关腹膜炎与各种风险因素之间的关联。 在随访期间(中位 1.52 年),364 名患者共经历了 539 次腹膜炎发作。全国粗腹膜炎发病率为 0.27 次/患者-年。在完全调整模型中,与腹膜炎相关的显著患者水平因素包括年龄(危险比 [HR],每增加 5 年为 1.07;95% 置信区间 [CI],1.01-1.14)、血清白蛋白水平(HR,每增加 1 g/dL 为 0.63;95% 置信区间 [CI],0.48-0.82)和持续非卧床腹膜透析(HR,1.31 vs 自动化腹膜透析;95% 置信区间 [CI],1.05-1.63)。在插入腹膜透析导管(HR,0.63;95% CI,0.51-0.78)或进行复杂的牙科手术(HR,0.74;95% CI,0.57-0.95)或较低的内窥镜检查(HR,0.69;95% CI,0.54-0.89)时采用抗生素预防措施与任何腹膜炎的较低危险性相关,而常规设施中更频繁的定期就诊与较高的危险性相关。 确定日本的风险因素可能有助于制定未来版本的指南和改善日本的临床实践。对腹膜透析相关腹膜炎的国家级风险因素进行调查有助于制定和实施当地的腹膜炎预防和治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信